The Endocrine Disruptor Page HomeSitemap
 

Chemical Safety Office
Evaluation and Licensing Division
Pharmaceutical and Food Safety Bureau
Ministry of Health, Labor and Welfare

Japanese

Last updated date: March 30, 2015
 

Home

 Advisory Committee

   Actions

     Scheme

     Overview

FAQs

Bisphenol A

Reports, etc.

Related reports

Links

Contact


 
Reports

Advisory Committee on Health Effects of Endocrine Disruptors
The Supplement II to the Intermediary Report
2_A

 

contents  Detailed contents  << prev

 

1) Causal relationship between exposure to endocrine disruptors and human health problems has not been established except for substances intended for pharmacological action such as DES.
2) Immediate measures can be taken if the risk of and level of exposure to specific substances are adequately evaluated if

  1. periods in which hormone regulation is unstable, such as the fetal period, are not involved,
  2. unexpected synergy of more than one substance does not appear, and
  3. unknown reactions in low doses do not exist.
(3) For solving the endocrine disruptor issue
This section reviews measures taken in Japan and other countries against endocrine disruptors, presents basic policies on chemical safety, information gathering and dissemination system, international collaboration and comprehensive research. Specific targets of research are categorized into (i) those needed for further accumulation of data and (ii) those to be addressed by up-to-date knowledge and leading-edge technology.

(4) Conclusion
The report is concluded with three propositions to be taking into account in implementation of measures against endocrine disruptors:
1) Many problems need further clarification to solve the endocrine disruptor issue.
2) The issue transcends national borders.
3) The issue can persist over generations.

(5) Appendix
Studies on the substances listed below, which are used as starting materials for plastics for eating utensils, are summarized. It is stated that immediate actions such as ban is not needed, but studies should be continued. General policies on future studies are presented.
1) Polycarbonates (bisphenol A)
2) Polystyrene (styrene monomer, dimer and trimer)
3) Polyvinyl chloride (phthalic acid esters)
 

contents  Detailed contents  << prev

 

 

About links, copyright, etc. Privacy policy

(C) 2005, 2016 Ministry of Health, Labour and Welfare, All Rights Reserved.